Danaher Posts Q3 Adjusted EPS of $2.11
DHR sits 37% above its 52-week low of $160.93 on elevated volume (2.2× avg).
Summary
Danaher reported third-quarter adjusted EPS of $2.11, alongside net earnings of $1.24 billion and EPS of $1.75, with sales of $6.6 billion and continuing operations EPS of $1.71. Operating cash flow came in at $1.9 billion and adjusted free cash flow at $1.6 billion. The print lands against a Q2 baseline of $870 million net earnings, up 60% year-over-year, when the $9.8 billion Masimo acquisition closed and core sales grew 3%. That deal more than doubled total debt to $26.6 billion, so the earnings figure carries extra weight as investors gauge whether the added leverage is being absorbed. This is the first quarterly report under new CEO Julie Sawyer Montgomery, who took over from Rainer Blair following the August 8-K announcement.
At the time of this announcement, DHR was trading at $221.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $157.6B. The 52-week trading range was $160.93 to $242.80. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.